ProSci

San Diego, United States Founded: 1998 • Age: 28 yrs Acquired By Genesee Scientific
Custom monoclonal, polyclonal, and single domain antibodies are developed.

About ProSci

ProSci is a Healthcare company based in San Diego (United States) founded in 1998, and was acquired by Genesee Scientific in February 2023. Custom monoclonal, polyclonal, and single domain antibodies are developed. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Reagents and Kits and Proteomics. Its competitors include GenScript, Epitomics and Vector Laboratories; 2 of its 3 listed competitors have raised funding.

Company details

ProSci was founded in 1998 and is based in San Diego, United States, operating in the biotechnology sector. Custom antibodies, encompassing monoclonal, polyclonal, and single domain types, are developed for research applications. Primary antibodies, secondary antibodies, and recombinant antibodies are produced, alongside lysates and molecular biology reagents including antibody beads, loading control antibodies, detection sets, immunoblots, peptides, and cell slides. Operations focus on antibody-related products and tools.

Key Metrics

Funding Insights of ProSci

  • Total Rounds 3
  • Last Round Grant β€” $600,000
  • First Round $600,000

    (Jan 2008)

  • Investors Count 1

All 3 funding rounds of ProSci with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jul 2014$600,000Grant––
Feb 2009$600,000Grant––
Jan 2008$600,000Grant––
Valuation history

2 investors in total: 2 institutional.

Investors in ProSci

ProSci has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include HHS and Genesee Scientific.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Public health and human services are overseen by HHS.
1953hhs.gov
Life science research products are sold via an online store.
1995geneseesci.comEl Cajon, United States
Premium access

Investor details for ProSci

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of ProSci

1 people are tracked at ProSci (1 in leadership).

NameRoleGroup
Scott McAllister
Chief Executive OfficerLeadership
Premium access

Complete people profiles for ProSci

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of ProSci

4 dated milestones of ProSci across 25 years, from founding to its latest funding, stage changes and deals.

  1. Founded ProSci is founded.
  2. Funding First funding round of $600K.
  3. Funding Latest funding round, Grant, of $600K.
  4. Exit Acquired by Genesee Scientific.

Competitors of ProSci

ProSci has 3 listed competitors in our database, 2 of them funded. They include GenScript, Epitomics and Vector Laboratories.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
genscript.com2002Piscataway, United States$15M5,260
Reagents and instruments are provided for life sciences research.
epitomics.com2001Burlingame, United States$16.21M
Monoclonal antibody technology and products are developed by Epitomics.
vectorlabs.com1976Burlingame, United States
Labeling and detection reagents immunohistochemistry studies and other life science research applications
Premium access

Detailed competitors of ProSci

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of ProSci

The website of ProSci (prosci-inc.com) receives about 9K visits a month.

  • Monthly visits
    9K

    ▲ 58.7% vs previous month

Similar websites

Websites whose visitors overlap most with ProSci. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
abcam.com
100%
602.8K#91,958View details
fitzgerald-fii.com
97%
View details
peprotech.com
93%
View details
novusbio.com
92%
199.6K#232,152View details
scbt.com
85%
444.3K#138,937View details
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 33 similar websites and full traffic analytics for ProSci

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 33 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Top companies in Life Sciences Platforms & Tools

3 companies that operate in the same segment as ProSci (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Medidata is recognized as a leading provider of SaaS solutions for clinical research.
1999New York, New York, United StatesUSD 41.5 M
AI-based solutions for health management are provided.
2015Dallas, Texas, United StatesUSD 2.8 B1,111
Real-world health data is provided for research and decisions.
2012Menlo Park, California, United StatesUSD 259.16 M
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Prosci

Prosci expands into new Fort Collins HQ
Bizwest β€’ 7 years ago
Premium access

Complete news archive for ProSci

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about ProSci

ProSci was founded in 1998 and raised its 1st funding round 10 years after it was founded.

ProSci is headquartered in San Diego, United States. It is registered at San Diego, California, United States.

ProSci was founded in 1998 and is based in San Diego, United States, operating in the biotechnology sector. Custom antibodies, encompassing monoclonal, polyclonal, and single domain types, are developed for research applications. Primary antibodies, secondary antibodies, and recombinant antibodies are produced, alongside lysates and molecular biology reagents including antibody beads, loading control antibodies, detection sets, immunoblots, peptides, and cell slides. Operations focus on antibody-related products and tools.

ProSci's top competitors include GenScript, Epitomics and Vector Laboratories.

ProSci has 2 investors. Key investors include HHS, and Genesee Scientific.

Yes. ProSci was acquired by Genesee Scientific in February 2023.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available